Trial Profile
A Phase III, randomized, double-blind, parallel-group, active control. multi-centre study to assess safety and efficacy of CIP-Isotretinoin in pediatric patients with severe recalcitrant nodular acne
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2015
Price :
$35
*
At a glance
- Drugs Isotretinoin (Primary)
- Indications Nodulocystic acne
- Focus Adverse reactions
- 05 Jan 2015 New trial record